|
INVESTMENT
OPPORTUNITIES
STANDARD
RB51
(For Brucellosis in cattle)
VetTech Marketing
Agreements
SCHERING-PLOUGH
Schering-Plough
markets the vaccine throughout Central and South America as well
as exclusive distribution rights for sub-Sahara Africa including South
Africa. Hertape, S.A., has manufacturing rights in Brazil.
PRONABIVE
PRONABIVE of Mexico, a quasi-governmental private company, to produce
and distribute in Mexico.
INDIAN IMMUNOLOGICAL LABORATORIES
Indian Immunological Laboratories and Vet Tech have a joint venture to manufacture and sell the vaccine in India.
CZV
CZU of Spain, to produce and
market throughout Europe, the Middle East and Northwest Africa and Russia.
COLORADO SERUM
The present brucellosis vaccine is manufacturered by Colorado
Serum in Denver, Colorado. VetTech in conjunction
with Colorado
Serum Co. is working with Malaysia and Indonesia to market the vaccine
in those countries and has opened a dialogue with China on introducing
the vaccine there.
|
|